| Term es nes pval sidak fdr geneset_size leading_edge leading_edge_size |
| Proteasome degradation 0.565785232427142 2.189125800786124 0.0285876977362984 0.9999999810151874 0.7930814181646851 44 P20618,Q9UL46,P60900,P28074,P28070,Q99436,P28072,P62333,O00231,P25788,P49721,P01889,P49720,O75832,P62191,P55036,Q15008,P62195 18 |
| Disruption of postsynaptic signaling by cnv 0.7730937234209009 2.176895032542474 0.0294884001521458 0.9999999892490252 0.7930814181646851 9 P27361,P28482,Q7L576,Q13555,Q06787 5 |
| Resistin as a regulator of inflammation 0.8181522946358034 2.0277295335475607 0.0425878596872668 0.999999999997408 0.7930814181646851 6 P19174,O15111,P31751,P27361 4 |
| Physicochemical features and toxicityassociated pathways 0.684822796826153 1.9856321465704003 0.0470741842759516 0.9999999999998544 0.7930814181646851 18 P62993,P28482,Q14012,Q16512,Q05397,P07197,P07196,P61160,P07737,P19174 10 |
| Tcell antigen receptor tcr pathway during staphylococcus aureus infection 0.6925018993920601 1.971230180422621 0.0486975532985425 0.9999999999999488 0.7930814181646851 14 Q15118,P27361,Q9UHD1,P62993,O43318,Q16512,P49841,P19174,O95433,O15111 10 |
| Relationship between inflammation cox2 and egfr 0.8406509945664024 1.9700187535307456 0.0488362213034123 0.9999999999999531 0.7930814181646851 5 P31751,P27361 2 |
| Regulation of actin cytoskeleton 0.5493638885467987 1.9601882874724712 0.0499737869615191 0.9999999999999776 0.7930814181646851 42 Q9Y6W5,P46108,Q9UQB8,Q13464,Q05397,Q16512,P35580,P12814,P46940,P07737,O60610,Q14155,Q8N8S7,P15311,O14974,O00443,Q9UBI6,P26038,P27361,P35241,P28482 21 |
| Mfap5 effect on permeability and motility of endothelial cells via cytoskeleton rearrangement 0.7157650818595124 1.9239219127858895 0.05436437210383 0.9999999999999988 0.7930814181646851 9 P27361,P28482,Q05397,P19174,P12814 5 |
| Nucleotidebinding oligomerization domain nod pathway 0.6945180810410456 1.8284786495313607 0.0674777470981951 1.0 0.7930814181646851 9 O15111 1 |
| Tgfbeta signaling in thyroid cells for epithelialmesenchymal transition 0.840372851733177 1.827634316890622 0.0676044519024627 1.0 0.7930814181646851 4 P27361,P19022,P28482 3 |
| Ras and bradykinin pathways in covid19 0.8384705511261461 1.8202461844167517 0.0687215227149871 1.0 0.7930814181646851 4 Q99829,P28482 2 |
| 15q112 copy number variation syndrome 0.7903170428108798 1.771039592340958 0.0765541180768101 1.0 0.7930814181646851 5 Q7L576,Q06787,Q96CW5 3 |
| Mfap5mediated ovarian cancer cell motility and invasiveness 0.7840909090909328 1.7461724247577928 0.0807809948978688 1.0 0.7930814181646851 5 P19174,P27361,P28482,Q05397 4 |
| Tcell receptor tcr signaling pathway 0.6297856033837643 1.723285098834247 0.0848369811078186 1.0 0.7930814181646851 19 P27361,P46108,P28482,P08670,Q16512,Q9UJU6,P19174,O15111 8 |
| 1q211 copy number variation syndrome 0.6410076731205977 1.706939011187911 0.0878333888845483 1.0 0.7930814181646851 12 Q9NPH0,Q9Y478,Q9UDY2 3 |
| Eukaryotic transcription initiation 0.6291413710810927 1.7064548650615663 0.0879234229606318 1.0 0.7930814181646851 18 P19388,Q92759,P18074,P13984 4 |
| Osteopontin signaling 0.7666004507600185 1.6760382041354451 0.0937307096213264 1.0 0.7930814181646851 5 O15111,P27361,P28482 3 |
| Angiogenesis 0.7563305589136122 1.6346756752200935 0.1021170543543135 1.0 0.7930814181646851 5 P19174,Q05397 2 |
| Canonical and noncanonical notch signaling 0.7906614224776863 1.6331268083249115 0.1024423293898126 1.0 0.7930814181646851 4 P55081,O15111 2 |
| Praderwilli and angelman syndrome 0.6962789175614742 1.6250976819014848 0.1041417467610741 1.0 0.7930814181646851 7 Q7L576,Q9UIS9,Q00534 3 |
| Cytosine methylation 0.7485100161679041 1.6030930436309168 0.1089141136022804 1.0 0.7930814181646851 5 O75874,P48735 2 |
| Map3k1 role in promoting and blocking gonadal determination 0.7462811814581984 1.5940791418765183 0.1109183100180906 1.0 0.7930814181646851 5 P28482,Q13464 2 |
| Tlr4 signaling and tolerance 0.7453237384457172 1.5902053094740725 0.1117885341093081 1.0 0.7930814181646851 5 O15111 1 |
| Mammary gland development pathway pregnancy and lactation stage 3 of 4 0.6860056112675378 1.581094250825587 0.1138564890842066 1.0 0.7930814181646851 7 O15111 1 |
| Tcell activation sarscov2 0.6120306018904665 1.5728957925912943 0.1157429495026773 1.0 0.7930814181646851 13 P27361,P62993,P28482,Q15382,P19174,O15111 6 |
| Pi3kakt signaling pathway 0.4463527147478342 1.5469516120624534 0.1218749141389397 1.0 0.7930814181646851 48 Q16512,Q05397,Q15382,P05556,P38398,O15111,P23588,P63151,Q14738,P62993,P07942,P31751,Q16513,Q16543,Q9UBI6,P11047,P27361,P28482,P06756,P63218,P30154,P49841,Q00534,O60573,P13807 25 |
| Il1 signaling pathway 0.6038089216240597 1.5394111866756897 0.1237039447432986 1.0 0.7930814181646851 14 P19174,O15111,P27361,P28482 4 |
| Ebsteinbarr virus lmp1 signaling 0.7293125597713452 1.5252773765373582 0.1271899281198751 1.0 0.7930814181646851 5 O15111,P28482 2 |
| Serotonin receptor 467 and nr3c signaling 0.717905563039484 1.4788642304452335 0.1391766050049796 1.0 0.7930814181646851 5 P27361 1 |
| Translation factors 0.5081716385636729 1.46316053968412 0.1434234555194016 1.0 0.7930814181646851 37 Q9H074,Q05639,P55884,P60842,P60228,Q9NR50,P23588,P63241,P55010,P49770,Q15056,Q14240,Q13144,O43432,O15372 15 |
| Kallmann syndrome 0.707744742299876 1.4374252731644748 0.1505971918566053 1.0 0.7930814181646851 5 Q9P2D1,P28482 2 |
| Cytosolic dnasensing pathway 0.5824237739741962 1.4274496577148863 0.153450326094676 1.0 0.7930814181646851 13 O15111 1 |
| Integrinmediated cell adhesion 0.5473701752626409 1.419991942495687 0.1556100268337237 1.0 0.7930814181646851 27 Q9Y490,P17655,P46108,P62993,P18206,P28482,P06756,P31751,P50552,Q16512,Q13464,Q05397,Q14155,P05556,O75116,Q15942 16 |
| Hypothesized pathways in pathogenesis of cardiovascular disease 0.7334421731970227 1.4062019664715075 0.1596641604129645 1.0 0.7930814181646851 4 P27361 1 |
| Initiation of transcription and translation elongation at the hiv1 ltr 0.6021756876096722 1.4048434900707727 0.1600678235494974 1.0 0.7930814181646851 9 P18615,Q8WX92,Q13547 3 |
| Ranklrank signaling pathway 0.5709360057269238 1.399160726733056 0.161764790665293 1.0 0.7930814181646851 17 P27361,P31751,Q05397,P19174,O15111 5 |
| Interleukin1 il1 structural pathway 0.5729595317483525 1.3697818208679466 0.1707550184881501 1.0 0.7930814181646851 10 O15111 1 |
| Mirna biogenesis 0.7220317720462169 1.3606893753667195 0.1736118735982277 1.0 0.7930814181646851 4 Q9HAV4,Q8WYQ5 2 |
| Genes controlling nephrogenesis 0.6293052344228567 1.3360205048744374 0.1815425712803975 1.0 0.7930814181646851 7 P11047,Q04721 2 |
| Il4 signaling pathway 0.5658344168549231 1.3353596599124389 0.1817586610508255 1.0 0.7930814181646851 10 O15111 1 |
| Inhibition of exosome biogenesis and secretion by manumycin a in crpc cells 0.607191865515846 1.3301563078026994 0.1834667764477187 1.0 0.7930814181646851 8 P61020,P27361,P31943 3 |
| Striated muscle contraction pathway 0.6785631865716779 1.31801840680497 0.1874974861978384 1.0 0.7930814181646851 5 O43707,P09493,P08670 3 |
| Synaptic signaling pathways associated with autism spectrum disorder 0.5600460814548023 1.3169947725064528 0.1878403768109346 1.0 0.7930814181646851 13 P31751,P27361,Q9Y478,Q15382 4 |
| Focal adhesion 0.4440103115855454 1.3133713834893066 0.1890578354004426 1.0 0.7930814181646851 44 Q9Y490,P46108,P62136,Q13464,Q05397,Q16512,O43707,P05556,P12814,Q15942,O60610,P62993,P07942,P31751,O14974,P62140,P27361,P18206,P28482,P06756,P50552,P49841,P11047 23 |
| Erbb signaling pathway 0.5456164899205675 1.288300980352427 0.1976412120051422 1.0 0.8186085335077853 19 P27361,P46108,P62993,P28482,P31751,Q16512,Q05397,P19174,Q13555 9 |
| Genes related to primary cilium development based on crispr 0.5495053917020263 1.2583048141870696 0.208281540777258 1.0 0.8339363368246234 11 Q8WXW3,Q7Z392,O95684 3 |
| Pathogenic escherichia coli infection 0.5300875960157045 1.2549293788311122 0.2095043978319608 1.0 0.8339363368246234 23 Q92747,Q9BVA1,Q9BUF5,Q92974,O15144,Q14247,P04350,P27348,Q16625,Q13464,P63104,P59998,P05556,O75116,P15311 15 |
| Tolllike receptor signaling pathway 0.5457777886075166 1.246472435306423 0.2125910028035491 1.0 0.8352591046262735 13 O15111,P31751,P27361 3 |
| Mevalonate pathway 0.6861467166544996 1.217346351096292 0.2234724658348521 1.0 0.863886549108218 4 Q15126 1 |
| Mapk cascade 0.6212922683704334 1.2157636287878728 0.2240749776642849 1.0 0.863886549108218 6 P27361,P28482 2 |
| Kisspeptinkisspeptin receptor system in the ovary 0.5598712741301302 1.2077550566697692 0.2271414935590319 1.0 0.8699636048666906 9 P31751,P27361,P28482 3 |
| G13 signaling pathway 0.5299459957943568 1.1830689216382253 0.2367818335748035 1.0 0.8796803877657853 16 Q7L576,P62140,Q16512,Q13464,P46940,P07737 6 |
| G1 to s cell cycle control 0.5099194820116242 1.1598380167249782 0.2461147626191908 1.0 0.8856934465653368 24 Q14181,P33992,P33993,Q9UBD5,P25205,P35244,P06493,P49736,Q13416,P33991,Q00534,P14635,P11802 13 |
| Pdgf pathway 0.5254339124057119 1.154555259086599 0.2482725972942729 1.0 0.8856934465653368 15 P27361,P28482,Q16512,P19174,O15111 5 |
| Hepatocyte growth factor receptor signaling 0.5150460706280839 1.098238031389977 0.2721005633332423 1.0 0.9024278637340594 14 P27361,P46108,P28482,Q16512,Q05397 5 |
| Ciliopathies 0.5072490182785189 1.0893445445940082 0.2760019763200816 1.0 0.9024278637340594 19 Q93008,P36405,P57076,Q15555,Q8WXW3,Q86Y56,Q9NQH7 7 |
| Nanoparticlemediated activation of receptor signaling 0.5327281646317237 1.0813412347986724 0.2795453514829606 1.0 0.9024278637340594 9 Q05397,P05556,P62993,P28482 4 |
| Nitric oxide metabolism in cystic fibrosis 0.6519079522283693 1.0808215962578822 0.2797764799272233 1.0 0.9024278637340594 4 Q86X55,Q99873,O14744 3 |
| Nucleotide excision repair 0.49201869472543 1.0765549367179972 0.2816791454223515 1.0 0.9024278637340594 25 P41208,P19447,Q92759,P35244,P18074 5 |
| Tnfrelated weak inducer of apoptosis tweak signaling pathway 0.5099697377001117 1.0698636345596058 0.2846806939843538 1.0 0.9024278637340594 13 O15111,P31751,P27361,P28482 4 |
| Endometrial cancer 0.5054934909166742 1.054909919499329 0.2914665251216832 1.0 0.904879599782995 15 P31751,P27361,P62993,P28482 4 |
| Hostpathogen interaction of human coronaviruses mapk signaling 0.5450418582214922 1.050507494462097 0.2934848470907027 1.0 0.904879599782995 8 P51812 1 |
| Rac1pak1p38mmp2 pathway 0.4979509685631386 1.0499225209336944 0.2937537363080196 1.0 0.904879599782995 20 P27361,O15111,P46108,P43246 4 |
| Mechanoregulation and pathology of yaptaz via hippo and nonhippo mechanisms 0.5216954454336191 1.0301464589733604 0.3029412588885889 1.0 0.911003393057394 9 P27348,P35240,Q16512 3 |
| Il17 signaling pathway 0.6082122875019738 1.0296996808736505 0.3031510054461286 1.0 0.911003393057394 5 P49841,P27361,P28482 3 |
| Mbdnf and probdnf regulation of gaba neurotransmission 0.5403664491460027 1.0295531578029695 0.3032198138757374 1.0 0.911003393057394 8 P63010,Q13464,P19174 3 |
| Exrna mechanism of action and biogenesis 0.728871204487 1.015926674825155 0.3096643052281396 1.0 0.9117684432478524 3 Q9HAV4 1 |
| Cellular proteostasis 0.6000691375265316 0.9965171416655147 0.3189989425441684 1.0 0.9117684432478524 5 Q9UHV9,Q99471 2 |
| Small cell lung cancer 0.4927621557874467 0.9960289494051656 0.3192360795270581 1.0 0.9117684432478524 16 P07942,P06756,P31751,O15111,Q05397,P05556,Q00534,P11047,P11802 9 |
| Chemokine signaling pathway 0.4742932152120113 0.99398549139711 0.3202299309435168 1.0 0.9117684432478524 26 Q9UBI6,P27361,P46108,P62993,P28482,P31751,Q16512,Q13464,P04899,Q05397,O15111 11 |
| Alpha 6 beta 4 signaling pathway 0.492120484773498 0.9884854244160164 0.3229149693431448 1.0 0.9117684432478524 15 P27361,P28482,P07942,Q05397,P11047 5 |
| Vitamin d in inflammatory diseases 0.5944812046605158 0.9737975590714448 0.3301570653208343 1.0 0.9199376410985064 5 O15111 1 |
| Thermogenesis 0.4560753525662978 0.9579759599959764 0.3380748809888625 1.0 0.9293269150052588 30 P51812,Q9Y478,O43772,Q15382 4 |
| Mecp2 and associated rett syndrome 0.4768608536841968 0.949470919111387 0.3423811557604415 1.0 0.9327984376940028 21 P52597,P35637,P67809,Q00013,Q03518,P31943 6 |
| Nrp1triggered signaling pathways in pancreatic cancer 0.4844844223496551 0.9438795753480286 0.3452311903917946 1.0 0.9364014146467704 12 P31751,P27361,Q05397 3 |
| Joubert syndrome 0.4747743413222913 0.9230141853502472 0.3559998128671222 1.0 0.940354971138929 19 Q15154,Q9UIS9,P41208,Q15382,Q8WXW3 5 |
| Aryl hydrocarbon receptor pathway wp2586 0.5116995423265195 0.9018588083739976 0.367131875252265 1.0 0.940354971138929 8 O00170,P28482 2 |
| Nsp1 from sarscov2 inhibits translation initiation in the host cell 0.4739796700798487 0.8945129261026862 0.3710475168886267 1.0 0.940354971138929 13 P55010,P60228,O15372 3 |
| Brainderived neurotrophic factor bdnf signaling pathway 0.3302644062493118 0.8926223913584305 0.3720594239797896 1.0 0.940354971138929 53 P27361,P84095,Q7L576,P19022,Q96S59,P10586,P19174,P51812,O15111 9 |
| Met in type 1 papillary renal cell carcinoma 0.4616086599035063 0.8892263771017845 0.3738814296037787 1.0 0.940354971138929 23 P27361,P46108,P62993,P28482,P31751,Q16512,Q05397,Q14241,P19174 9 |
| Metapathway biotransformation phase i and ii 0.4589262276910493 0.8857864935817542 0.3757325893205874 1.0 0.940354971138929 24 Q86UY6 1 |
| Modulators of tcr signaling and t cell activation 0.4722845486899948 0.8850724563084812 0.3761175538234407 1.0 0.940354971138929 11 O15111 1 |
| Tca cycle nutrient use and invasiveness of ovarian cancer 0.6896574392550912 0.8733165365836629 0.3824905695173286 1.0 0.940354971138929 3 P27361 1 |
| Dna replication 0.4466484084691149 0.8717909793343602 0.3833224165971389 1.0 0.940354971138929 28 P33993,Q9UBD5,P40938,P35244,Q13416,P33991,Q14181 7 |
| Ketogenesis and ketolysis 0.5379766424752924 0.8658483466872039 0.3865733323442253 1.0 0.940354971138929 6 O43772 1 |
| Mevalonate arm of cholesterol biosynthesis pathway 0.4814704533599533 0.8455672522489048 0.3977942006120412 1.0 0.9533528744297732 9 Q15126 1 |
| Exerciseinduced circadian regulation 0.4620664505916646 0.8388865960269336 0.4015329502365117 1.0 0.9544207396276302 14 P31689,Q96PU8,P21266,Q16851 4 |
| Interleukin11 signaling pathway 0.4593583887661601 0.8311314719728174 0.405899362320206 1.0 0.9569858042395628 16 O15111 1 |
| Epo receptor signaling 0.4738986602692854 0.811373575621571 0.4171511691730267 1.0 0.9658010111693238 9 Q15118,P27361,P28482 3 |
| Methionine de novo and salvage pathway 0.4875661417596757 0.7959681967555572 0.42605052081137 1.0 0.9688219740695648 8 Q9BV57 1 |
| Parkinubiquitin proteasomal system pathway 0.4057340334795574 0.7883433088125102 0.4304959214755328 1.0 0.9688219740695648 36 Q9BVA1,Q9BUF5,Q0VDF9,P04350,P62333,O00231,O75832,P62191,P55036,Q15008,P62195 11 |
| Melanoma 0.4433415982676326 0.7514892164940078 0.4523582881259129 1.0 1.0 15 P27361,P62993,P28482,P31751,Q16512,Q00534,P11802 7 |
| Dna mismatch repair 0.4367747933163676 0.7340024287940307 0.4629472578133231 1.0 1.0 19 Q9UQ84,P35244,P43246 3 |
| Target of rapamycin tor signaling 0.4364076364989074 0.7191449417663264 0.4720516190934951 1.0 1.0 10 Q9Y478 1 |
| Mapk signaling pathway 0.3728624629789114 0.7139365049697224 0.4752664429396827 1.0 1.0 41 Q9Y4G8,O15111,P51812 3 |
| Kit receptor signaling pathway 0.432447702040188 0.70867002619634 0.4785292695672882 1.0 1.0 18 P19174,P51812,P27361 3 |
| Follicle stimulating hormone fsh signaling pathway 0.4503124064457474 0.7065303434944734 0.4798583895939876 1.0 1.0 9 P27361,Q15382 2 |
| Micrornas in cardiomyocyte hypertrophy 0.4262820249933932 0.7008510081503463 0.4833960014915519 1.0 1.0 22 P27361,P28482,P31751,Q13144,O15111 5 |
| Cardiac hypertrophic response 0.4313542040630985 0.6939841727846022 0.4876921346178642 1.0 1.0 14 O15111,P31751,P27361 3 |
| Leptin signaling pathway 0.3987352404001183 0.6884196438786406 0.4911885569772098 1.0 1.0 33 P27361,P28482,Q07666,Q05397,O00629,P19174,P18031,O15111 8 |
| Splicing factor nova regulated synaptic proteins 0.4280939708654212 0.6845526546217655 0.4936262520141095 1.0 1.0 17 Q9UNS2,P19022,Q12955,Q13555,Q9NQX3 5 |
| Pi3kaktmtor signaling pathway and therapeutic opportunities 0.5200206958550344 0.6781551792683903 0.4976733075565731 1.0 1.0 5 Q15118,Q15382 2 |
| Gaba receptor signaling 0.4759168129141409 0.6774230986365977 0.4981375468962279 1.0 1.0 7 P63010,O94973,Q96CW1,Q9NQX3 4 |
| B cell receptor signaling pathway 0.4239015981562694 0.6721401859891439 0.5014944554090424 1.0 1.0 19 P46108,P62993,P28482,P19174,O15111 5 |
| Bdnftrkb signaling 0.4545976776690043 0.6552034128291351 0.5123367973141308 1.0 1.0 8 P19174,P28482,Q15382 3 |
| Glioblastoma signaling pathways 0.4188697967391641 0.6529247682158771 0.5138047803947168 1.0 1.0 20 P27361,P28482,P31751,O00443,Q00534,P19174,P38398 7 |
| Androgen receptor signaling pathway 0.3989256208122134 0.6436407434964085 0.5198084233881723 1.0 1.0 30 Q9UBS8,Q13464,Q13547,Q05397,O95251,Q8N2W9,Q86X55,P38398 8 |
| Serotonin htr1 group and fos pathway 0.4350831327720076 0.6405226358087031 0.5218328778620234 1.0 1.0 9 P04899,P27361 2 |
| Aryl hydrocarbon receptor pathway wp2873 0.482193938579022 0.6397404522996439 0.5223413517254418 1.0 1.0 6 O00170,Q16543 2 |
| Dna repair pathways full network 0.3044971416367215 0.6360376144128975 0.5247519057846404 1.0 1.0 52 P41208,P19447,Q92759,Q9UQ84,P18074,P43246 6 |
| Fgfr3 signaling in chondrocyte proliferation and terminal differentiation 0.4645122785580604 0.6310956941011053 0.5279779563963791 1.0 1.0 7 P27361 1 |
| Embryonic stem cell pluripotency pathways 0.4167150594303512 0.6272290320544063 0.5305091152583006 1.0 1.0 14 P62993,P28482,P31751,P49841,P61160 5 |
| Thymic stromal lymphopoietin tslp signaling pathway 0.4166760776777873 0.6269949187242051 0.5306625659434991 1.0 1.0 13 P27361 1 |
| Mapk and nfkb signaling pathways inhibited by yersinia yopj 0.8588064046579394 0.6263251156183941 0.5311017159454101 1.0 1.0 2 O15111 1 |
| Tolllike receptor signaling related to myd88 0.8588064046579394 0.6263251156183941 0.5311017159454101 1.0 1.0 2 O15111 1 |
| Neovascularisation processes 0.8588064046579384 0.6263251156183914 0.5311017159454119 1.0 1.0 2 P27361 1 |
| Glycogen synthesis and degradation 0.4113707395590227 0.6051864772041875 0.5450550999267834 1.0 1.0 16 Q14738,P30154,P49841,Q16851,P06737,P13807 6 |
| Angiopoietinlike protein 8 regulatory pathway 0.376454129797638 0.5842964385762194 0.5590208878598812 1.0 1.0 34 P27361,P46108,P13807,P31751,P18031,Q15382,P51812,Q9Y478 8 |
| Cell cycle 0.3147408578019134 0.5545525287391025 0.5792007667988994 1.0 1.0 48 Q9UQE7,Q13547,P33991,P14635,P11802,Q9UBD5,P06493,P49736,P63208,Q9UJX2,O96017,Q13416,P33992,P27348,P33993,P53350,P25205,P49841,Q13309,Q00534 20 |
| Inflammatory response pathway 0.8302765647743882 0.5458969020706195 0.5851368079804047 1.0 1.0 2 P11047 1 |
| Hippoyap signaling pathway 0.5107652488869947 0.5441540175566211 0.5863354912629051 1.0 1.0 4 P27348,P35240 2 |
| Wnt signaling pathway 0.3961630678283095 0.5370072853834387 0.591262581677569 1.0 1.0 15 P28482,Q9BTU6,P49841,Q00534,O14641,Q13363 6 |
| Nonsmall cell lung cancer 0.3939279802457474 0.5315296528324118 0.595051798470748 1.0 1.0 18 Q15118,P27361,P28482,P31751,Q00534,P19174,Q9HC35 7 |
| Phosphoinositides metabolism 0.453032303166508 0.527506068660834 0.5978422032567299 1.0 1.0 6 O00443,P19174 2 |
| Envelope proteins and their potential roles in edmd physiopathology 0.391570685444613 0.5238492967284538 0.6003833628348176 1.0 1.0 19 Q14739,P27361,Q8NF91,P28482 4 |
| Immune response to tuberculosis 0.585841752987902 0.5200193170734659 0.603050111450611 1.0 1.0 3 Q03518 1 |
| Aspirin and mirnas 0.8206695778748165 0.5197212329137727 0.6032578856593047 1.0 1.0 2 Q15118 1 |
| Il6 signaling pathway 0.3891110159310574 0.5069113487918823 0.6122170223820924 1.0 1.0 14 P27361,P62993,P28482,Q13547,P49841 5 |
| Prostaglandin synthesis and regulation 0.4026442856355233 0.505932782461108 0.6129038377714942 1.0 1.0 9 P12429 1 |
| Epithelial to mesenchymal transition in colorectal cancer 0.3757554396679289 0.4972408149514619 0.6190192425268481 1.0 1.0 27 Q04721,P27361,P62993,P28482,P31751,P19022,Q16625,Q16512,P49841 9 |
| Transcription cofactors ski and skil protein partners 0.494452503721784 0.4882070197013793 0.6254032128771052 1.0 1.0 4 Q13547 1 |
| Nongenomic actions of 125 dihydroxyvitamin d3 0.3977095269977003 0.486332396023937 0.6267315137489398 1.0 1.0 9 P27361,Q13555 2 |
| Focal adhesion pi3kaktmtorsignaling pathway 0.2940564148577939 0.4861892949299657 0.6268329606148777 1.0 1.0 50 Q9UBI6,P11047,P27361,Q14738,P62993,P28482,P07942,P06756,P23588,P31751,Q9Y376,P30154,Q05397,Q15382,O00443,Q9BRX2,O60573,P13807 18 |
| Glucuronidation 0.4412216641005181 0.4837293623811348 0.6285779519841856 1.0 1.0 6 O95394 1 |
| 16p112 distal deletion syndrome 0.4372376271461248 0.4692162435946576 0.6389150759281306 1.0 1.0 6 Q99873,P62993 2 |
| Type ii interferon signaling ifng 0.4218541203095756 0.4656967688900508 0.6414325654871349 1.0 1.0 7 P01889 1 |
| Pdgfrbeta pathway 0.4072090332657029 0.4655648505776411 0.6415270074510091 1.0 1.0 8 P27361 1 |
| Il9 signaling pathway 0.3919500092989679 0.4637943206211551 0.6427951127532803 1.0 1.0 9 P27361,P28482 2 |
| 22q112 copy number variation syndrome 0.3466707376118441 0.4618328271115125 0.6442012079479107 1.0 1.0 36 P30038,Q14974,Q9UQ13,P62140,Q8IZ69,Q96DF8,Q9BW71,P45973,Q8WYQ5,Q92973,Q9NQ50 11 |
| Congenital generalized lipodystrophy cgl 0.7935953420669631 0.4487253251344064 0.6536298132943315 1.0 1.0 2 P31751 1 |
| Ras signaling 0.3511953805855232 0.4433751333547978 0.657494419135997 1.0 1.0 33 Q9UBI6,P27361,P31751,Q9UQ13,P19174,P61020,O15111 7 |
| Burn wound healing 0.3845478605490274 0.4353953511238128 0.6632754841984418 1.0 1.0 9 Q99439,P07737,P08670 3 |
| Camkk2 pathway 0.3694652340945612 0.4294877217006471 0.6675683273900068 1.0 1.0 12 Q14155,P27361,P28482 3 |
| Regulatory circuits of the stat3 signaling pathway 0.3962992219698038 0.4248675032758015 0.6709332654170523 1.0 1.0 8 P27361 1 |
| Netrinunc5b signaling pathway 0.3686486219825791 0.4237637882319254 0.6717380895645244 1.0 1.0 17 P27361,Q05397,P28482,P30154 4 |
| Il3 signaling pathway 0.3683926773112953 0.4237057662754718 0.6717804093435054 1.0 1.0 13 P27361,P28482,P27348 3 |
| Arrhythmogenic right ventricular cardiomyopathy 0.3677864601149205 0.4202660965767023 0.6742910742674086 1.0 1.0 14 P06756,P12814,P19022,O43707 4 |
| Translation inhibitors in chronically activated pdgfra cells 0.3639132658449376 0.4160718565703414 0.6773574231139692 1.0 1.0 22 P60842,Q15118,P27361,Q53EL6,P28482,P23588,P31751,Q14240 8 |
| Dna irdamage and cellular response via atr 0.3377818242078509 0.4052437878976262 0.6852983211871413 1.0 1.0 35 P27694,O43324,O96017,O60921,P33993,P53350,Q9UQ84,Q13472,P06493,Q92900,P43246,P49736,P38398,Q9BXW9,Q9NVI1 15 |
| Primary focal segmental glomerulosclerosis fsgs 0.3623728057082432 0.4036622106995964 0.686461131805763 1.0 1.0 20 P35579,P08670,P19022,P27348,Q05397,O43707,P19174,P11047,P46939 9 |
| Il7 signaling pathway 0.3898151156824042 0.4013227153737611 0.6881825415919551 1.0 1.0 8 P27361,P28482 2 |
| Insulin signaling 0.2798028413312563 0.3980941745448261 0.6905607683286377 1.0 1.0 50 P27361,P46108,P62993,P28482,P13807,P31751,O43318,Q12846,Q15382,O00443,Q15833,P49841,O60343,P10586,P51812,P18031 16 |
| Il2 signaling pathway 0.3592487982480911 0.3953098334218297 0.6926142431642754 1.0 1.0 10 P27361,P28482 2 |
| 4hydroxytamoxifen dexamethasone and retinoic acids regulation of p27 expression 0.385501437669556 0.3859418080155746 0.699539766499367 1.0 1.0 8 P27361,P28482 2 |
| Neural crest cell migration during development 0.3979649673561493 0.3802161394764961 0.7037849797311666 1.0 1.0 7 P31751 1 |
| Mirna regulation of prostate cancer signaling pathways 0.3663734767362167 0.3686436907081973 0.7123933251980246 1.0 1.0 9 P49841,P62993,P28482 3 |
| Eicosanoid synthesis 0.5313154500027764 0.3599814076696903 0.7188610373495101 1.0 1.0 3 P09960 1 |
| Bile acids synthesis and enterohepatic circulation 0.4531138026548047 0.3565295455143482 0.7214440297240787 1.0 1.0 4 P27361,P28482 2 |
| Pancreatic adenocarcinoma pathway 0.3477337321987576 0.3552432558423964 0.7224073617659674 1.0 1.0 23 P27361,P31751,O15111,Q00534 4 |
| Regulation of sister chromatid separation at the metaphaseanaphase transition 0.3752583211927318 0.3503772793385337 0.7260555754889628 1.0 1.0 8 O60566,O60216,Q9UQE7,O43684 4 |
| Egfegfr signaling pathway 0.2844995954258064 0.349115551587606 0.7270025617669837 1.0 1.0 47 Q92783,P46108,P28482,Q05397,P19174,P51812,Q96J02,P46940,Q99700 9 |
| Prion disease pathway 0.3465225075350057 0.3489952592757195 0.7270928686355955 1.0 1.0 10 P27361,Q05397 2 |
| Factors and pathways affecting insulinlike growth factor igf1akt signaling 0.3606386285283225 0.3485386572000746 0.7274356873315189 1.0 1.0 9 Q15118,P49841,P49770,Q9Y478 4 |
| Pyrimidine metabolism 0.2945907331908109 0.3395472227454444 0.7341975290879523 1.0 1.0 44 P19388,Q9NRF8,O15514,P27708,Q14181,Q9H773,Q9BZX2,P31350 8 |
| Hepatitis b infection 0.3360971321590771 0.3285756563899932 0.7424764506866601 1.0 1.0 27 P27361,P28482,P31751,Q15904,O15111 5 |
| Osteoblast differentiation and related diseases 0.3417906450395506 0.3240475140203674 0.7459020623415205 1.0 1.0 14 O00443,P27361,P28482 3 |
| Mrna processing 0.3695023149665284 0.3187048910085812 0.7499503054320253 1.0 1.0 107 O75400,Q99873,O75533,P35637,Q13243,Q9UHI6,P67809,O60942,O43390,P61978,Q01081,P52756,P22626,P51003,P52272,O95400,Q9UBU9,Q01130,Q14103,Q86U44,P55795,Q9UKA9,O60508,Q9H0D6,P31943,P38159,Q12996 27 |
| Agerage pathway 0.3368838452076492 0.3078426762322154 0.7582020464827677 1.0 1.0 20 O15111 1 |
| Insulin signaling in adipocytes diabetic condition 0.4119487620787458 0.3044766958153895 0.760764744510698 1.0 1.0 5 P31751 1 |
| Insulin signaling in adipocytes normal condition 0.4119487620787458 0.3044766958153895 0.760764744510698 1.0 1.0 5 P31751 1 |
| Cell migration and invasion through p75ntr 0.3883566924647315 0.3038665381847963 0.7612295717376387 1.0 1.0 6 P31751 1 |
| Male infertility 0.3354172396284485 0.3015016222613036 0.7630320131398127 1.0 1.0 19 P34896,Q9UFC0 2 |
| Type i collagen synthesis in the context of osteogenesis imperfecta 0.3309520202735514 0.2909084261273905 0.7711213567725943 1.0 1.0 12 Q32P28 1 |
| Gastrin signaling pathway 0.3134116177184752 0.2826450397164512 0.7774489507753544 1.0 1.0 33 P27361,P46108,P62993,P28482,Q16512,Q13464,Q05397,P19174,O15111 9 |
| Retinoblastoma gene in cancer 0.2552892639256272 0.2679984137758522 0.7887005397127704 1.0 1.0 50 Q14527,Q9UQE7,Q13547,P33991,O95347,P14635,P11802,Q9UNN5,P27694,P26358,P06493,P35244,P31350,P26583,P09429,Q16204,P33993,P40938,P25205,Q13309,Q00534 21 |
| Cysteine and methionine catabolism 0.3756922180122456 0.2655809014984789 0.7905619959177836 1.0 1.0 6 P48637,P48506,P17174,P23526,P25325 5 |
| Tca cycle in senescence 0.3451344026087255 0.2545122269927928 0.7990998592568248 1.0 1.0 8 P23368 1 |
| Neural crest differentiation 0.3179525181407879 0.2501675809770718 0.8024577549078258 1.0 1.0 12 Q04721,Q9NR77,P19022,Q13547,P49841,O14641 6 |
| Complement system 0.3160251459739413 0.2409347349572229 0.8096057003848116 1.0 1.0 14 P04899,P26885,Q99829,P11047 4 |
| Serotonin receptor 2 and elksrfgata4 signaling 0.3876669463691318 0.2368896771175756 0.8127423785565715 1.0 1.0 5 P27361 1 |
| Chromosomal and microsatellite instability in colorectal cancer 0.3108217333699342 0.2233229973297997 0.8232841299135574 1.0 1.0 19 P31751,P27361,P43246 3 |
| Rett syndrome causing genes 0.3090423676430361 0.2223167473805261 0.8240673157742682 1.0 1.0 13 P46108,Q13547 2 |
| Tnfalpha signaling pathway 0.3078808966757598 0.2175989725136894 0.8277415851246648 1.0 1.0 22 O15111 1 |
| 16p112 proximal deletion syndrome 0.2993541281800973 0.2045608819996637 0.8379152206834473 1.0 1.0 27 P27361,Q16204 2 |
| Nucleotide excision repair in xeroderma pigmentosum 0.2838048942706693 0.2029298292581012 0.8391898789496837 1.0 1.0 36 P41208,P19447,Q92759,P35244,P18074 5 |
| Tgfbeta signaling pathway 0.2697884300315181 0.1987372884087377 0.8424682538534001 1.0 1.0 41 P63208,Q15118,P62993,P28482,Q01082,O43318,Q13464,Q05397,O95405,Q7Z3T8,Q13547,P06493,P05556,P35658,Q96J02 15 |
| Il5 signaling pathway 0.2985310715603778 0.1957641035217713 0.8447948076271077 1.0 1.0 12 P27361,P62993,P28482 3 |
| Influence of laminopathies on wnt signaling 0.2978974560521549 0.1941253611231255 0.8460777240389508 1.0 1.0 12 O60725 1 |
| Dna damage response only atm dependent 0.2923281377933252 0.1766477732184713 0.8597850665150932 1.0 1.0 23 Q15118,P62993,P28482,P31751,P09429,O00443,P49841,O14641 8 |
| Egfr tyrosine kinase inhibitor resistance 0.292988864403064 0.1756417914984324 0.860575367837795 1.0 1.0 20 P27361,O60573,P62993,P28482,P31751,P19174 6 |
| Thyroid hormones production and peripheral downstream signaling effects 0.2914995145815327 0.1717545337497545 0.8636305110545845 1.0 1.0 18 P62993,P28482,P06756,Q15382,P49841,O60343 6 |
| Intraflagellar transport proteins binding to dynein 0.3098096937886742 0.1613285276043853 0.8718346557628982 1.0 1.0 8 O43237,P63167 2 |
| Alzheimers disease 0.2910909343599939 0.1563409885610927 0.8757642493486946 1.0 1.0 90 Q9BVA1,P20618,P27361,Q9BUF5,P28482,P28074,P28070,Q99436,P28072,P31751,P04350,P25788,P49721,P62191,O15111,P49720,Q15008 17 |
| Lipid metabolism pathway 0.2796271045457615 0.14766852159607 0.8826043753578381 1.0 1.0 14 Q9Y478 1 |
| Head and neck squamous cell carcinoma 0.2777250491110702 0.1424995935308514 0.8866854004102935 1.0 1.0 15 P31751,Q15382 2 |
| Common pathways underlying drug addiction 0.2859069579007807 0.1386198724298881 0.8897505389936338 1.0 1.0 9 P27361,P62140,P28482 3 |
| Energy metabolism 0.2733248836368546 0.1345708054343705 0.8929512254895506 1.0 1.0 14 Q99873,Q13555,Q9Y478,Q13547 4 |
| Hepatitis c and hepatocellular carcinoma 0.2699832442157335 0.1307800234990906 0.8959493261936216 1.0 1.0 12 P38398,P27361,P31350,P62993 4 |
| Gastric cancer network 2 0.2707113193094514 0.1283430833107193 0.8978774714565776 1.0 1.0 15 Q14739,Q9NVI1,P40938 3 |
| Nucleotide metabolism 0.2669035468517703 0.1234001281267627 0.9017902556190098 1.0 1.0 13 P19623,P31350 2 |
| Measles virus infection 0.2658276882195452 0.1217131821480594 0.9031261730160568 1.0 1.0 26 O15111 1 |
| Alzheimers disease and mirna effects 0.2804204546803762 0.1168673087828807 0.9069652044027748 1.0 1.0 93 Q9BVA1,P20618,P27361,Q9BUF5,P28482,P28074,P28070,Q99436,P28072,P31751,P04350,P25788,P49721,P62191,O15111,P49720,Q15008 17 |
| Spinal cord injury 0.2653908901323678 0.1165729685521627 0.9071984596169655 1.0 1.0 21 P27361,P04083,P14174,P28482 4 |
| Interferon type i signaling pathways 0.2616104895491616 0.1108836742698174 0.9117085918061416 1.0 1.0 16 Q99873,Q53EL6,P23588,P46108 4 |
| Atr signaling 0.4078160827946351 0.1086727743380279 0.913462036866118 1.0 1.0 3 O60921 1 |
| Endoderm differentiation 0.2501667086540592 0.1073587915677529 0.9145043450683852 1.0 1.0 33 O14981,Q8N7H5,Q92541,P11047 4 |
| Bladder cancer 0.2940990177114018 0.1011150339812362 0.919459143821918 1.0 1.0 7 P28482 1 |
| Breast cancer pathway 0.2448693460613382 0.0922195300182156 0.9265236214526318 1.0 1.0 30 Q04721,P27361,P11802,P62993,P28482,P31751,P49841,Q00534,P38398,O14641 10 |
| Cannabinoid receptor signaling 0.274738927485495 0.0918777377692151 0.9267951793211702 1.0 1.0 8 P27361 1 |
| Neuroinflammation and glutamatergic signaling 0.2489002142265284 0.0898635320913014 0.9283956610376504 1.0 1.0 21 P34896 1 |
| Cohesin complex cornelia de lange syndrome 0.2484023866499197 0.0892683654229814 0.9288686344065032 1.0 1.0 18 Q14738,Q9UQE7,P30154,P53350,Q29RF7,P06493,Q7Z5K2,Q9Y6X3 8 |
| Ovarian infertility 0.5868995633187795 0.0881493945413009 0.9297579379750364 1.0 1.0 2 P11802 1 |
| Malignant pleural mesothelioma 0.238463382288455 0.087217613469656 0.9304985391821888 1.0 1.0 80 Q16512,Q15382,Q05397,Q15022,P38398,O14641,P23588,P51812,Q15118,P62993,P07942,P31751,P19022,Q15047,P61964,Q9Y478,P27361,P28482,P06756,P09429,P49841,P11047,Q13363 23 |
| Ampactivated protein kinase ampk signaling 0.2470705274991522 0.0871808499608374 0.9305277609101056 1.0 1.0 20 P31751,Q9Y478 2 |
| Prolactin signaling pathway 0.2433868598174797 0.0834956785333188 0.9334574134263788 1.0 1.0 24 P27361,P62993,P28482,Q16512,Q05397,P18031 6 |
| Lncrna in canonical wnt signaling and colorectal cancer 0.2341840619108214 0.0711899726801234 0.94324656181129 1.0 1.0 19 P61978,Q13363 2 |
| Myometrial relaxation and contraction pathways 0.2249011785472144 0.0623552370654584 0.950279941199252 1.0 1.0 23 P19174,Q99439,Q13555,Q9UBI6 4 |
| Overlap between signal transduction pathways contributing to lmna laminopathies 0.2237325301263568 0.0615366933645532 0.950931792686106 1.0 1.0 15 P49841,O60725,Q13547 3 |
| Vegfavegfr2 signaling pathway 0.2776756737628783 0.0599675755284711 0.9521814591762396 1.0 1.0 184 P35579,Q14157,Q9NYL9,P46108,P31689,Q16625,Q13464,Q13547,Q16512,Q05397,O00560,Q9Y520,Q96J02,P46940,P55036,P07737,Q9UNN5,Q01105,O15372,P61421,Q92783,Q9Y678,O00231,P48735,Q15369,P15311,Q00610,P04083,O43852,P62993,Q14241,Q96KB5,P19174,Q9H2U1,Q96PU8,P18031,Q01844,P27361,P28482,P06756,P09429,P24666,P49841,P47756 44 |
| Leukocyteintrinsic hippo pathway functions 0.265014577259488 0.0560306706249937 0.9553173739070652 1.0 1.0 7 P51153,Q16539,P27348,Q96GC9,P61586,Q13043 6 |
| Nanoparticle triggered regulated necrosis 0.5406113537117949 0.0551542183571826 0.95601560183981 1.0 1.0 2 Q13546 1 |
| Interactions between loxl4 and oxidative stress pathway 0.3543972044263256 0.0549484276830236 0.9561795504176364 1.0 1.0 3 Q8TAG9,Q16543 2 |
| Matrix metalloproteinases 0.5388646288209652 0.0541934206376213 0.9567810625537684 1.0 1.0 2 Q9UGU0 1 |
| Ciliary landscape 0.2356010127659929 0.0538883201335082 0.957024142328286 1.0 1.0 112 Q13547,O60942,Q9NVA1,O60343,P07197,P43246,P07196,P33991,P46940,P08670,Q9UNS2,Q96S59,Q15555,Q8IVV7,O95400,Q99627,O60645,P61962,P55081,P33993,P43034,P62333,P63167,Q9NQH7,Q9UBW8 25 |
| Unfolded protein response 0.346649670395486 0.0496113528755459 0.9604320994875956 1.0 1.0 3 Q9Y3I0 1 |
| Hair follicle development organogenesis part 2 of 3 0.2930381590445635 0.0468124617623509 0.9626626968730272 1.0 1.0 4 P13591,P35222,P05556 3 |
| Regulation of wnt bcatenin signaling by small molecule compounds 0.2824327729203933 0.0445838128451922 0.9644390453077928 1.0 1.0 5 P49841 1 |
| Foxa2 pathway 0.2781532908098469 0.0356407877965809 0.9715687850094424 1.0 1.0 4 O15439 1 |
| Cancer immunotherapy by ctla4 blockade 0.4439592430858806 0.0245831302082313 0.9803874753776574 1.0 1.0 2 O00459 1 |
|
|
